![Axel Bouchon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Axel Bouchon
Oprichter bij
BrainLuxury, Inc.
Profiel
Axel Bouchon is the founder of BrainLuxury, Inc., founded in 2020, serving as Chairman since 2020.
Dr. Bouchon is the founder of Matter Neuroscience, Inc., founded in 2019, serving as Chief Executive Officer since 2019.
Current jobs include Chief Executive Officer at AMLOne UG (haftungsbeschränkt) since 2016, Chairman at Brain Games Corp.
since 2020, and Venture Partner at ARCH Venture Partners LLC since 2021.
Former jobs include Chief Executive Officer at Moderne Capital LLC, Non-Executive Director at Brii Biosciences Ltd. (China) from 2021 to 2022, Head-Lifescience Center at Bayer AG from 2015 to 2019, and Member at Moderna, Inc. Education includes a doctorate degree from Eberhard Karls Universität Tübingen, conferred in 2002.
Actieve functies van Axel Bouchon
| Bedrijven | Functie | Begin |
|---|---|---|
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 01-12-2021 |
BrainLuxury, Inc.
 BrainLuxury, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures and commercializes nutritional brain supplements products | Oprichter | 01-01-2020 |
Brain Games Corp.
 Brain Games Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in neuroscience and tech to help people track and boost their happiness | Voorzitter | 01-01-2020 |
AMLOne UG (haftungsbeschränkt) | Algemeen Directeur | 01-07-2016 |
Matter Neuroscience
 Matter Neuroscience Packaged SoftwareTechnology Services Develops mobile application for neurological reward systems | Algemeen Directeur | 01-01-2019 |
Eerdere bekende functies van Axel Bouchon
| Bedrijven | Functie | Einde |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Directeur/Bestuurslid | 30-09-2022 |
| BAYER AG | Corporate Officer/Principal | 01-01-2019 |
| MODERNA, INC. | Corporate Officer/Principal | - |
Moderne Capital LLC
 Moderne Capital LLC Investment ManagersFinance Moderne Ventures invests in companies located in the United States with revenues of USD 1 - 30 million. The firm focuses across a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Algemeen Directeur | - |
Opleiding van Axel Bouchon
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
34
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Eberhard Karls Universität Tübingen
 Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderne Capital LLC
Moderne Capital LLC Investment ManagersFinance Moderne Ventures invests in companies located in the United States with revenues of USD 1 - 30 million. The firm focuses across a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Finance |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Brii Biosciences Ltd. (China)
 Brii Biosciences Ltd. (China) BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Brain Games Corp.
Brain Games Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in neuroscience and tech to help people track and boost their happiness | Commercial Services |
BrainLuxury, Inc.
BrainLuxury, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures and commercializes nutritional brain supplements products | Health Technology |
AMLOne UG (haftungsbeschränkt) | |
Matter Neuroscience
Matter Neuroscience Packaged SoftwareTechnology Services Develops mobile application for neurological reward systems | Technology Services |
